Danaher Cuts Fiscal Year Targets, Gives 2Q Outlook

By Kimberly Chin

Danaher Corp. (DHR) has cut its full-year 2019 guidance to reflect the dilution regarding its equity offering to fund its $21.4 billion acquisition of General Electric Co.'s (GE) GE BioPharma.

For the year, Danaher now anticipates earnings of $3.34 to $3.42 a share, down from its previous forecast of $3.85 to $3.95. It expects adjusted profit of $4.72 to $4.80, a cut from its prior guidance of $4.75 to $4.85. Analysts polled by Refinitiv were expecting full-year earnings of $3.98 a share and adjusted earnings of $4.79 a share.

For the current quarter, the company projects earnings between 89 cents and 92 cents a share and adjusted earnings between $1.13 and $1.16 a share. Analysts expect earnings of 99 cents a share and adjusted earnings of $1.19 a share for the second quarter.

Shares of Danaher, which has gained 21% for the year, were mostly flat in premarket trading on low trading volumes.

Write to Kimberly Chin at kimberly.chin@wsj.com

(END) Dow Jones Newswires

April 18, 2019 06:44 ET (10:44 GMT)

Danaher (NYSE:DHR)
Historical Stock Chart
From Mar 2024 to Apr 2024